This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Before arriving at the ED, the patient had been initiated on a course of bupropion and transdermal nicotine (21 mg/24 hr) for smoking cessation. He had received bupropion hydrochloride extended ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

The mechanism of action of bupropion is unknown, as is the case with other antidepressants. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms.

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Seizures associated with pediatric single-substance exposures are steadily increasing, according to a study presented at the ...

Objectives. To identify predictors of smoking abstinence at the end of medication use that could assist in the optimal use of a sustained-release (SR) form of bupropion for treating cigarette smokers.

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

Discover all the brand names or Trade names of generic drug called Bupropion. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

On October 11, the recall was classified as a class II recall by the FDA—a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health ...

Granules India's US subsidiary receives FDA approval for generic Bupropion Hydrochloride Extended-Release Tablets, expanding ...